The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional) |
93.310 |
RFA-RM-20-016 |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional) |
93.310 |
RFA-RM-20-015 |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-018 |
| Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-20-017 |
| Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed) |
93.113, 93.847, 93.989 |
RFA-DK-20-017 |
| Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
93.113, 93.313, 93.399, 93.865 |
PAR-20-282 |
| Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) |
93.113, 93.313, 93.399, 93.865 |
PAR-20-281 |
| Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed) |
93.113, 93.847 |
RFA-DK-20-019 |
| Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed) |
93.113, 93.847 |
RFA-DK-20-018 |
| NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
PAR-20-278 |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) |
93.121, 93.172, 93.393, 93.396 |
PAR-20-277 |
| Limited Competition for the Continuation of the Look AHEAD (Action for Health in Diabetes) Study (U01 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-21-028 |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
93.121, 93.172, 93.393, 93.396 |
PAR-20-276 |
| NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed) |
93.113 |
RFA-ES-20-015 |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
93.173, 93.242, 93.279, 93.395, 93.855 |
PAR-20-271 |
| Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional) |
93.866 |
PAR-20-269 |
| Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) |
93.393, 93.396, 93.399 |
RFA-CA-20-045 |
| BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed) |
93.113, 93.121, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-DA-21-006 |
| NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
93.279 |
PAR-20-267 |
| NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional) |
93.853 |
RFA-NS-21-001 |
| NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20 Clinical Trial Optional) |
93.853 |
RFA-NS-21-002 |
| Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) |
93.213, 93.242, 93.273, 93.393, 93.866 |
PAR-20-266 |
| Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
93.855 |
PAR-20-256 |
| PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.307, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-20-265 |
| PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
93.068, 93.070, 93.073, 93.084, 93.103, 93.113, 93.121, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.286, 93.307, 93.316, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93 |
PA-20-260 |
| PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
93.068, 93.070, 93.073, 93.084, 93.103, 93.113, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.307, 93.316, 93.326, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.859, 93.865, 93 |
PA-20-262 |
| PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
93.068, 93.070, 93.073, 93.084, 93.103, 93.113, 93.136, 93.172, 93.173, 93.213, 93.233, 93.242, 93.262, 93.273, 93.279, 93.307, 93.316, 93.326, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.847, 93.859, 93.865, 93 |
PA-20-261 |
| Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed |
93.279 |
RFA-DA-21-026 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) |
93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.853, 93.865, 93.866, 93.867 |
PAR-20-130 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.286, 93.350, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.859, 93.866, 93.867, 93.879 |
PAR-20-128 |
| Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
93.847 |
RFA-DK-20-021 |
| SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
93.121, 93.173, 93.233, 93.242, 93.273, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867 |
PAR-20-129 |
| Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) |
93.113, 93.121, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.351, 93.361, 93.398, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879 |
PA-20-251 |
| Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) |
93.393 |
RFA-CA-20-037 |
| Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
93.113, 93.279, 93.846, 93.853, 93.867 |
PAR-20-253 |
| Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) |
93.847 |
RFA-DK-20-011 |
| Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) |
93.847 |
RFA-DK-20-012 |
| Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) |
93.396, 93.866 |
RFA-CA-20-040 |
| Biomarkers of Dietary Intake and Exposure (U2C Clinical Trial Required) |
93.847 |
RFA-DK-20-005 |
| Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-20-007 |
Search Results 2681-2720 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
